Cardiac Pharmacology: Difference between revisions

Jump to navigation Jump to search
no edit summary
No edit summary
No edit summary
Line 368: Line 368:
|Heart Failure
|Heart Failure
|Captopril: 12.5mg 3 times daily
|Captopril: 12.5mg 3 times daily
|ESC Guidelines (European Heart Journal (2012) 33, 2569–2619
|ESC Guidelines (European Heart Journal (2012) 33, 2569–2619 doi:10.1093/eurheartj/ehs215):  
doi:10.1093/eurheartj/ehs215):  
Post STEMI: Class IA
Post STEMI: Class IA


ESC and EASD Guidelines (European Heart Journal doi: 10.1093/eurheart/ehl261)
ESC and EASD Guidelines (European Heart Journal doi: 10.1093/eurheart/ehl261)  
Diabetic patients: Class IC
Diabetic patients: Class IC


Line 400: Line 399:
|
|
|Angiotensin Receptor Blockers
|Angiotensin Receptor Blockers
|Losartan. Candesartan |Hypertension
|Losartan. Candesartan
|Hypertension
|Losartan: 50mg once daily
|Losartan: 50mg once daily
|ESC and EASD Guidelines (European Heart Journal doi: 10.1093/eurheart/ehl261)
|ESC and EASD Guidelines (European Heart Journal doi: 10.1093/eurheart/ehl261)
Line 507: Line 507:
AF (Stable flutter): Class IC
AF (Stable flutter): Class IC
Prophylaxis of SVT during pregnancy: Class IIaB
Prophylaxis of SVT during pregnancy: Class IIaB
|
|-
|-
|
|
Line 542: Line 543:
doi:10.1093/eurheartj/ehs104):
doi:10.1093/eurheartj/ehs104):
Angina in symptomatic (NYHA class II-IV) HF and LVD: Class IIaA
Angina in symptomatic (NYHA class II-IV) HF and LVD: Class IIaA
|
|-
|-
|Anti-Arrhythmics
|Anti-Arrhythmics
467

edits

Navigation menu